title: Cost-effectiveness of biologics as first-line treatment of rheumatoid arthritis: case closed?
authors.forename: Maarten
authors.initials: M
authors.lastname: Boers
mesh_terms: D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D006801:Humans; D007155:Immunologic Factors / Q000191:economics / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D007155:Immunologic Factors